CSIMarket Company Name, Ticker, Industry, else..
 
Seastar Medical Holding Corp  (NASDAQ: ICU)
 
Price: $2.9100 $0.03 1.042%
Day's High: $3.0220000743865967 Week Perf: -5.83 %
Day's Low: $ 2.86 30 Day Perf: -3.64 %
Volume (M): 25,647 52 Wk High: $ 12.50
Volume (M$): $ 0 52 Wk Avg: $3.98
Open: $2.91 52 Wk Low: $2.07



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 4
 Employees 17
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Seastar Medical Holding Corporation is a healthcare company that operates and manages medical facilities and providers. The corporation aims to provide high-quality medical services and innovative technologies to improve patient care and outcomes. It may own and operate hospitals, clinics, and other healthcare facilities, and may also offer telemedicine services. Seastar Medical Holding Corporation may collaborate with other healthcare organizations and professionals to expand its reach and offer comprehensive medical solutions.


   Company Address: 3513 Brighton Blvd., Suite 410 Denver 80216 CO
   Company Phone Number: 427-8100   Stock Exchange / Ticker: NASDAQ ICU


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AQB   -9.92%    
BWV   -24.35%    
XPER   -3.95%    
• View Complete Report
   



Stocks on the Move

Seastar Medical Holding Corporation Weathering Controversy and Charting a Path Forward,

Published Wed, Aug 7 2024 8:12 PM UTC

Seastar Medical Holding Corporation: Navigating Controversy and Market ChallengesIn recent months, Seastar Medical Holding Corporation (NASDAQ: ICU) has found itself embroiled in controversy and facing significant market challenges. The company s shares have trailed the overall market performance, leaving investors concerned about its future prospects. However, amidst the un...
Announcement

Shareholder Alert Class Action Lawsuit Filed Against SeaStar Medical for Alleged Securities Violations

Published Fri, Jul 26 2024 3:17 PM UTC

Shareholder Alert: Class Action Lawsuit Filed Against SeaStar Medical Holding Corporation for Alleged Securities Law Violations In a significant legal development, Pomerantz LLP has announced the filing of a class action lawsuit against SeaStar Medical Holding Corporation (NASDAQ: ICU) and specific officers. This lawsuit, initiated in the United States District Court for the...
Stocks on the Move

SeaStar Medical Holding Corporations Recent Offering and Lawsuit Challenges Fail to Dampen Strong Market Performance

Published Tue, Jul 16 2024 8:46 AM UTC

SeaStar Medical Holding Corporation (NASDAQ: ICU) recently closed a registered direct offering, raising $10 million in funds. The offering, priced at-the-market under Nasdaq rules, saw the issuance and sale of nearly 950,000 aggregate shares. Despite this positive development, SeaStar Medical Holding Corp shares have faced significant challenges in the market, leading to a c...
Stocks on the Move

SeaStar Medical Holding Corporation Facing Securities Fraud Lawsuit and Shareholder Approval Violations

Published Tue, Jul 9 2024 4:30 PM UTC

SeaStar Medical Holding Corporation (NASDAQ: ICU) is facing significant legal and regulatory challenges as it becomes embroiled in a securities fraud lawsuit and potential violations of shareholder approval rules. The ICU investors now have a unique opportunity to lead the lawsuit against the company with the support of the Schall Law Firm. In addition, SeaStar Medical recen...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.94
Price to Sales (Expected) -
Price to Book 2.77
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.6
Working Capital Ratio 1.89
Leverage Ratio (MRQ) 1.01
Total Debt to Equity 0.03
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.08 $
Revenues (TTM) 0.42 $
Cash Flow (TTM) 0.75 $
Cash 1.7 $
Book Value 1.05 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 100,765
Net Income per Employee (TTM) -801,588
Receivable Turnover Ratio (TTM) 8.11
Inventory Turnover Ratio (TTM) 1.78
Asset Turnover Ratio (TTM) 0.14

Profitability Ratios Current
Gross Margin (MRQ) 91.22 %
Operating Margin (MRQ) -616.42 %
Net Margin (MRQ) -606.5 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Seastar Medical Holding's Segments
Quelimmune    406.5 % of total Revenue
Single Reportable Segment    180.49 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.